185 related articles for article (PubMed ID: 26306688)
1. Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females.
Behrman-Lay AM; Paul RH; Heaps-Woodruff J; Baker LM; Usher C; Ances BM
J Neurovirol; 2016 Feb; 22(1):93-103. PubMed ID: 26306688
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic network connectivity abnormalities in HIV-infected individuals over age 60.
Guha A; Wang L; Tanenbaum A; Esmaeili-Firidouni P; Wendelken LA; Busovaca E; Clifford K; Desai A; Ances BM; Valcour V
J Neurovirol; 2016 Feb; 22(1):80-7. PubMed ID: 26265137
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals.
Baker LM; Paul RH; Heaps-Woodruff JM; Chang JY; Ortega M; Margolin Z; Usher C; Basco B; Cooley S; Ances BM
J Neuroimmune Pharmacol; 2015 Sep; 10(3):487-92. PubMed ID: 25900078
[TBL] [Abstract][Full Text] [Related]
4. HIV clades B and C are associated with reduced brain volumetrics.
Ortega M; Heaps JM; Joska J; Vaida F; Seedat S; Stein DJ; Paul R; Ances BM
J Neurovirol; 2013 Oct; 19(5):479-87. PubMed ID: 24078556
[TBL] [Abstract][Full Text] [Related]
5. Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment.
Gawron N; Choiński M; Szymańska-Kotwica B; Pluta A; Sobańska M; Egbert AR; Desowska A; Wolak T; Horban A; Firląg-Burkacka E; Bieńkowski P; Sienkiewicz-Jarosz H; Scińska-Bieńkowska A; Biswal B; Rao SM; Bornstein R; Łojek E
J Neurovirol; 2019 Feb; 25(1):9-21. PubMed ID: 30298203
[TBL] [Abstract][Full Text] [Related]
6. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
Bogoch II; Davis BT; Venna N
J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
[TBL] [Abstract][Full Text] [Related]
7. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
8. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
9. Independent effects of HIV, aging, and HAART on brain volumetric measures.
Ances BM; Ortega M; Vaida F; Heaps J; Paul R
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):469-77. PubMed ID: 22269799
[TBL] [Abstract][Full Text] [Related]
10. Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.
Duro M; Rebelo I; Barreira S; Sarmento-Castro R; Medeiros R; Almeida C
Int J STD AIDS; 2015 Oct; 26(11):796-802. PubMed ID: 25281540
[TBL] [Abstract][Full Text] [Related]
11. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.
McCutchan JA; Wu JW; Robertson K; Koletar SL; Ellis RJ; Cohn S; Taylor M; Woods S; Heaton R; Currier J; Williams PL
AIDS; 2007 May; 21(9):1109-17. PubMed ID: 17502721
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.
Kumar AM; Ownby RL; Waldrop-Valverde D; Fernandez B; Kumar M
J Neurovirol; 2011 Feb; 17(1):26-40. PubMed ID: 21165787
[TBL] [Abstract][Full Text] [Related]
13. Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era.
Sanford R; Fernandez Cruz AL; Scott SC; Mayo NE; Fellows LK; Ances BM; Collins DL
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):563-570. PubMed ID: 28129254
[TBL] [Abstract][Full Text] [Related]
14. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
15. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
[TBL] [Abstract][Full Text] [Related]
16. Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy.
Mwamburi DM; Wilson IB; Jacobson DL; Spiegelman D; Gorbach SL; Knox TA; Wanke CA
Clin Infect Dis; 2005 Jan; 40(1):167-73. PubMed ID: 15614708
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.
Jeremy RJ; Kim S; Nozyce M; Nachman S; McIntosh K; Pelton SI; Yogev R; Wiznia A; Johnson GM; Krogstad P; Stanley K;
Pediatrics; 2005 Feb; 115(2):380-7. PubMed ID: 15687448
[TBL] [Abstract][Full Text] [Related]
19. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility.
Fabbiani M; Grima P; Milanini B; Mondi A; Baldonero E; Ciccarelli N; Cauda R; Silveri MC; De Luca A; Di Giambenedetto S
Antivir Ther; 2015; 20(4):441-7. PubMed ID: 25516553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
